| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |